| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $322.2M | -1.1% | +7.2% |
| Cost of Revenue | $94.1M | +0.9% | -9.0% |
| Gross Profit | $228.1M | -1.9% | +15.8% |
| R&D Expense | $65.9M | +1.7% | +9.5% |
| SG&A Expense | $30.9M | +3.0% | -2.9% |
| Operating Income | $78.7M | -12.2% | +301.0% |
| Pre-tax Income | $67.5M | -13.5% | +986.1% |
| Income Tax | $15.8M | -12.9% | +2975.7% |
| Net Income | $51.7M | -13.6% | +806.4% |
| EPS (Basic) | $0.60 | -13.0% | +757.1% |
| EPS (Diluted) | $0.59 | -13.2% | +883.3% |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $309.3M | +1.6% | -4.0% |
| Accounts Receivable | $111.2M | +0.1% | +4.2% |
| Current Assets | $498.7M | +1.2% | +0.7% |
| Total Assets | $3.40B | -0.5% | -2.6% |
| Current Liabilities | $120.6M | +3.5% | -21.9% |
| Long-term Debt | $982.1M |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $339.2M | — | — |
| Capital Expenditures | $1.6M | — | — |
| Investing Cash Flow | -$38.7M | — | — |
| Financing Cash Flow | -$287.2M | — | — |
| Free Cash Flow | $337.5M | — | — |
| -9.2% |
| Total Liabilities | $1.26B | -0.5% | -7.3% |
| Stockholders' Equity | $2.13B | -0.6% | +0.4% |